'I Think This Is The Beginning of The End of The Pandemic': Doc Claims Chloroquine Is Highly EffectiveChris Menahan
Apr. 02, 2020
Jonathan Pentland Arrest: Incident Reports Say Black Suspect Sexually Harassed Woman, Tried to Snatch Baby
Diversity Training Done Right!
Republican Utah Governor Says He's Proud Of The Utah Jazz For Racially Discriminating Against White Kids
Tucker: U.S. Has 'Two Systems Of Justice - One For The Allies of The People in Charge & One For Their Enemies'
DOJ Says No Charges For Capitol Police Officer Filmed Executing Unarmed Air Force Vet Ashli Babbitt
Dr Stephen Smith, founder of The Smith Center for Infectious Diseases and Urban Health, said Wednesday night on Fox News that he's been treating all his patients with hydroxychloroquine and azithromycin and not one who has been on the regimen for over five days has needed to be intubed.
From Fox News, "Dr. Stephen Smith on effectiveness of hydroxychloroquine: 'I think this is the beginning of the end of the pandemic'":
“I think this is the beginning of the end of the pandemic. I’m very serious,” Smith, an infectious disease specialist, told host Laura Ingraham.The New York Times reported Wednesday on yet another study, this time from China, suggesting hydroxychloroquine is effective.
From The New York Times, "Malaria Drug Helps Virus Patients Improve, in Small Study":
The malaria drug hydroxychloroquine helped to speed the recovery of a small number of patients who were mildly ill from the coronavirus, doctors in China reported this week.From the study:
From February 4 to February 28, 2020, 62 patients suffering from COVID-19 were diagnosed and admitted to Renmin Hospital of Wuhan University. All participants were randomized in a parallel-group trial, 31 patients were assigned to receive an additional 5-day HCQ (400 mg/d) treatment, Time to clinical recovery (TTCR), clinical characteristics, and radiological results were assessed at baseline and 5 days after treatment to evaluate the effect of HCQ. Key findings: For the 62 COVID-19 patients, 46.8% (29 of 62) were male and 53.2% (33 of 62) were female, the mean age was 44.7 (15.3) years. No difference in the age and sex distribution between the control group and the HCQ group. But for TTCR, the body temperature recovery time and the cough remission time were significantly shortened in the HCQ treatment group. Besides, a larger proportion of patients with improved pneumonia in the HCQ treatment group (80.6%, 25 of 32) compared with the control group (54.8%, 17 of 32). Notably, all 4 patients progressed to severe illness that occurred in the control group. However, there were 2 patients with mild adverse reactions in the HCQ treatment group. Significance: Among patients with COVID-19, the use of HCQ could significantly shorten TTCR and promote the absorption of pneumonia.Dr Jeff Colyer, the former governor of Kansas who is a practicing physician, reported Sunday in the Wall Street Journal that the combination of hydroxychloroquine and azithromycin was showing "promising" results in coronavirus patients in Kansas and noted how doctors and patients in China who were already on the drug seemed to avoid catching COVID-19:
During the initial Chinese outbreak, Wuhan doctors observed that patients with lupus—a disease for which HC is a common treatment—did not seem to develop Covid-19. Of 178 hospital patients who tested positive, none had lupus and none were on HC. None of this Wuhan hospital's dermatology department's 80 lupus patients were infected with the novel coronavirus. The Wuhan doctors hypothesized that this may be due to long-term use of HC. They treated 20 Covid-19 patients with HC. Their result: "Clinical symptoms improve significantly in 1 to 2 days. After five days of chest CT examination, 19 cases showed significant absorption improvement."Hydroxychloroquine is very cheap and easy to mass produce.
Follow InformationLiberation on Twitter, Facebook, Gab and Minds.